Evidence map›Paper›PMID 29852244›Full record

ArticleNeuroscience2018

Gain-of-function KCNJ6 Mutation in a Severe Hyperkinetic Movement Disorder Phenotype.

Gabriella A Horvath, Yulin Zhao, Maja Tarailo-Graovac, Cyrus Boelman, Harinder Gill, Casper Shyr, James Lee, Ingrid Blydt-Hansen, Britt I Drögemöller, Jacqueline Moreland and 5 more

Abstract readCase Reports
In one paragraph

Article in Neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Polymorphisms ofBiomolecules · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Lipodystrophy-associated progeroid syndromes.Hormones (Athens, Greece) · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Advances in Targeting GIRK Channels in Disease.Trends in pharmacological sciences · 2021
    Review
  15. Comparison of KHandbook of experimental pharmacology · 2021
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 5 countries.

Gabriella A HorvathDivision of Biochemical Diseases, Department of Pediatrics, B.C. Children's Hospital, University of British Columbia, Vancouver, Canada; BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada. Electronic address: ghorvath@cw.bc.ca.
Yulin ZhaoDept. of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Maja Tarailo-GraovacBC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, Canada; Institute of Physiology and Biochemistry, Faculty of Biology, The University of Belgrade, Belgrade, Serbia; Department of Biochemistry, Molecular Biology, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada; Department of Medical Genetics, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada.
Cyrus BoelmanDivision of Pediatric Neurology, Department of Pediatrics, B.C. Children's Hospital, University of British Columbia, Vancouver, Canada.
Harinder GillDepartment of Medical Genetics, University of British Columbia, Vancouver, Canada.
Casper ShyrCentre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.
James LeeDivision of Pediatric Neurology, Department of Pediatrics, B.C. Children's Hospital, University of British Columbia, Vancouver, Canada.
Ingrid Blydt-HansenQueens University, Kingston, Canada.
Britt I DrögemöllerBC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada; Department of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Jacqueline MorelandDepartment of Biochemistry, Molecular Biology, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada; Department of Medical Genetics, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Canada.
Colin J RossDepartment of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Wyeth W WassermanBC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
Andrea MasottiBambino Gesù Children's Hospital, IRCCS, Research Laboratories, Rome, Italy.
Paul A SlesingerDept. of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: Paul.Slesinger@mssm.edu.
Clara D M van KarnebeekDivision of Biochemical Diseases, Department of Pediatrics, B.C. Children's Hospital, University of British Columbia, Vancouver, Canada; BC Children's Hospital Research Institute, University of British Columbia, Vancouver, Canada; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada; Department of Pediatrics and Clinical Genetics, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands.
University of British Columbia · CABC Children's Hospital · CAAllen Institute for Brain Science · USIstituti di Ricovero e Cura a Carattere Scientifico · ITQueen's University · CAUniversity of Belgrade · RSUniversity of Calgary · CA

Funding

Structural Analysis of Alcohol-dependent Activation of GIRKsR01AA018734 · NIAAA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Paul A Slesinger · 2010 to 2026
$6.6M
Dissecting Mechanisms of GABAB-GIRK Plasticity with PsychostimulantsR01DA037170 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MOSS, STEPHEN J, SLESINGER, PAUL A · 2014 to 2018
$2.1M
NIAAA NIH HHS R01 AA018734NIDA NIH HHS R01 DA037170
6 · The paper itself

Abstract

Here, we describe a fourth case of a human with a de novo KCNJ6 (GIRK2) mutation, who presented with clinical findings of severe hyperkinetic movement disorder and developmental delay, similar to the Keppen-Lubinsky syndrome but without lipodystrophy. Whole-exome sequencing of the patient's DNA revealed a heterozygous de novo variant in the KCNJ6 (c.512T>G, p.Leu171Arg). We conducted in vitro functional studies to determine if this Leu-to-Arg mutation alters the function of GIRK2 channels. Heterologous expression of the mutant GIRK2 channel alone produced an aberrant basal inward current that lacked G protein activation, lost K

Indexed as

Gain of Function MutationBrainChild, PreschoolDNA Mutational AnalysisElectroencephalographyFemaleG Protein-Coupled Inwardly-Rectifying Potassium ChannelsHumansHyperkinesisMovement DisordersG Protein-Coupled Inwardly-Rectifying Potassium ChannelsKCNJ6 protein, humanchannelopathyinward rectifierKCNJ6K(IR)3movement disorderweaver mouse

Identifiers

PMID29852244
PMCPMC6679957
OpenAlexW2805948500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.